Phase II study of combination therapy with Irinotecan and S-1 in patients with progressive colorectal cancer after FOLFOX regimen
Phase of Trial: Phase II
Latest Information Update: 03 May 2017
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Irinotecan (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 30 Apr 2017 Status changed from active, no longer recruiting to completed.
- 02 Sep 2008 New trial record.